Humana Inc. (NYSE:HUM) Shares Bought by GF Fund Management CO. LTD.

GF Fund Management CO. LTD. raised its stake in Humana Inc. (NYSE:HUM - Free Report) by 66.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,993 shares of the insurance provider's stock after acquiring an additional 1,985 shares during the period. GF Fund Management CO. LTD.'s holdings in Humana were worth $1,321,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. LFA Lugano Financial Advisors SA boosted its stake in Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after acquiring an additional 45 shares during the period. OFI Invest Asset Management acquired a new position in shares of Humana during the fourth quarter worth approximately $33,000. Riverview Trust Co acquired a new position in shares of Humana during the first quarter worth approximately $34,000. Garde Capital Inc. acquired a new position in shares of Humana during the first quarter worth approximately $36,000. Finally, Transce3nd LLC acquired a new position in shares of Humana during the fourth quarter worth approximately $38,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Price Performance

NYSE HUM opened at $238.58 on Friday. The stock has a market capitalization of $28.79 billion, a P/E ratio of 16.87, a P/E/G ratio of 1.81 and a beta of 0.44. Humana Inc. has a 1 year low of $212.45 and a 1 year high of $406.46. The business's fifty day moving average is $240.29 and its two-hundred day moving average is $258.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.91 and a current ratio of 1.91.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.42% and a return on equity of 14.47%. The company had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. During the same period in the previous year, the business earned $7.23 EPS. The company's revenue was up 8.4% on a year-over-year basis. On average, research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.48%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is currently 25.04%.

Analysts Set New Price Targets

HUM has been the subject of several analyst reports. Bank of America reduced their price objective on Humana from $320.00 to $260.00 and set a "neutral" rating for the company in a research report on Tuesday, June 17th. Raymond James Financial upgraded Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective for the company in a research report on Thursday, May 1st. Wall Street Zen upgraded Humana from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Cantor Fitzgerald reiterated a "neutral" rating and set a $290.00 price objective on shares of Humana in a research report on Thursday, May 1st. Finally, Oppenheimer boosted their price objective on Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. Sixteen equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $280.76.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.